Form 8-K - Current report:
SEC Accession No. 0001144204-19-035361
Filing Date
2019-07-22
Accepted
2019-07-22 16:05:15
Documents
1
Period of Report
2019-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv525580_8k.htm 8-K 19398
  Complete submission text file 0001144204-19-035361.txt   20806
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 19965685
SIC: 2836 Biological Products, (No Diagnostic Substances)